Tizzani A - Search Results

1

[Alternative tests to PSA for prostate cancer diagnosis].

Defilippi E, Zitella A, Tizzani A. Defilippi E, et al. Among authors: tizzani a. Urologia. 2011 Apr-Jun;78(2):75-81. doi: 10.5301/RU.2011.7973. Urologia. 2011. PMID: 21553390 Review. Italian.

2

Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series.

Oderda M, Zitella A, Richiardi L, Tizzani A, Gontero P. Oderda M, et al. Among authors: tizzani a. Arch Ital Urol Androl. 2010 Dec;82(4):135-8. Arch Ital Urol Androl. 2010. PMID: 21341547

3

Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?

Gontero P, Gillo A, Fiorito C, Oderda M, Pacchioni D, Casetta G, Peraldo F, Zitella A, Tizzani A, Ricceri F. Gontero P, et al. Among authors: tizzani a. Urol Int. 2014;92(2):136-42. doi: 10.1159/000351961. Epub 2013 Sep 25. Urol Int. 2014. PMID: 24080613

4

BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder.

Casetta G, Gontero P, Zitella A, Pelucelli G, Formiconi A, Priolo G, Martinasso G, Mengozzi G, Aimo G, Viberti L, Tizzani A. Casetta G, et al. Among authors: tizzani a. Urol Int. 2000;65(2):100-5. doi: 10.1159/000064848. Urol Int. 2000. PMID: 11025432 Clinical Trial.

5

Fatal haematuria in a patient with an orthotopic neobladder and chronic liver failure.

Oderda M, Mondino P, Lucca I, Fiorito C, Gillo A, Zitella A, Greco A, Tizzani A, Gontero P. Oderda M, et al. Among authors: tizzani a. Urol Int. 2009;83(3):368-9. doi: 10.1159/000241686. Epub 2009 Oct 13. Urol Int. 2009. PMID: 19829044

6

Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia.

Zitella A, Berruti A, Destefanis P, Mengozzi G, Torta M, Ceruti C, Casetta G, Mosca A, Greco A, Rolle L, Aimo G, Aroasio E, Tizzani A, Dogliotti L, Fontana D; Gruppo Oncologico Urologico Piemontese (GOUP). Zitella A, et al. Among authors: tizzani a. Clin Chim Acta. 2007 Feb;377(1-2):103-7. doi: 10.1016/j.cca.2006.08.034. Epub 2006 Sep 5. Clin Chim Acta. 2007. PMID: 17034778

7

Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer.

Priolo G, Gontero P, Martinasso G, Mengozzi G, Formiconi A, Pelucelli G, Zitella A, Casetta G, Viberti L, Aimo G, Tizzani A. Priolo G, et al. Among authors: tizzani a. Clin Chim Acta. 2001 Mar;305(1-2):47-53. doi: 10.1016/s0009-8981(00)00416-2. Clin Chim Acta. 2001. PMID: 11249922

8

[Update on epidemiology and risk factors of prostate cancer].

Oderda M, Mondino P, Zitella A, Gontero P, Tizzani A. Oderda M, et al. Among authors: tizzani a. Urologia. 2008 Jul-Sep;75(3):143-8. Urologia. 2008. PMID: 21086342 Italian.

9

Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.

Chiappino I, Destefanis P, Addeo A, Galetto A, Cucchiarale G, Munoz F, Zitella A, Ferrando U, Fontana D, Ricardi U, Tizzani A, Bertetto O. Chiappino I, et al. Among authors: tizzani a. Am J Clin Oncol. 2007 Jun;30(3):234-8. doi: 10.1097/01.coc.0000256706.16313.49. Am J Clin Oncol. 2007. PMID: 17551298 Clinical Trial.

10

Clear cell sarcoma of the kidney with invasion of the inferior vena cava.

Rosso D, Ghignone GP, Bernardi D, Zitella A, Casetta G, De Zan A, Tizzani A. Rosso D, et al. Among authors: tizzani a. Urol Int. 2003;70(3):251-2. doi: 10.1159/000068756. Urol Int. 2003. PMID: 12660471 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page